Wistar Institute scientists have designed a two-vaccine approach that not only targets the tumors’ unique molecular identity ...

The Las Vegas Desert Dogs host their annual Tucker Out Lymphoma game, honoring Tucker Williams while raising awareness and support for pediatric cancer research. #PaidForContent ...

T cell lymphomas are notoriously difficult to treat because immunotherapy, despite being one of the most effective therapies for treating cancer, can't easily distinguish cancerous T cells from ...

A new statistical analysis of patients with follicular lymphoma, made possible by 15 years of follow-up data from a SWOG and ...

Glo-BNHL global trial opens sites in Netherlands and Austria to trial multiple new treatments for B-cell Non-Hodgkin Lymphoma ...

Twenty years. That's how long Robert Oman has been cancer-free, thanks to a clinical trial offered at the University of ...

One moment changed Lonetta Bradford’s life forever.

Debi Weiss thought her fatigue and weakness was a seasonal illness, but her condition quickly worsened.

Jana Batson was diagnosed with Hodgkin lymphoma after she insisted upon having a swollen lymph node examined. In addition to ...

A team of Santa Barbara high school students leading a fundraising campaign for Blood Cancer United will host a community fundraiser Wednesday, March 18 ...

Ipsen telegraphed plans to acquire Epizyme and the FDA-approved Tazverik in June 2022, two years after the med’s clearance in the U.S. as both an epithelioid sarcoma and follicular lymphoma treatment.

“[I thought] I had an intolerance to vodka," said Claire Dougherty ...